Benserazide Hydrochloride, offered under REFARMED CHEMICALS—a subsidiary of the DKSH Group—is an essential pharmaceutical ingredient tailored for the robust demands of the medical industry. Specifically formulated for the management of Parkinson’s disease, Benserazide Hydrochloride serves as a monoamine oxidase B (MAO-B) inhibitor. When synergistically combined with levodopa, it not only amplifies the efficacy of the treatment but also mitigates associated side effects such as nausea, enhancing the quality of life for patients suffering from this neurodegenerative condition. Our Benserazide Hydrochloride emerges as a white to off-white crystalline powder, a testament to its purity and quality. The compound exhibits admirable water solubility, ensuring ease of formulation and bioavailability. Its molecular identity, C10H14N2O3·HCl, with a molecular weight of 234.7 g/mol, aligns with rigorous pharmaceutical prerequisites. Our product delivers through a strict adherence to quality with an assay value ranging from 98.5% to 101.0%, guaranteeing a high-caliber substance with minimal impurity content. REFARMED CHEMICALS prioritizes safety and compliance, validating Benserazide Hydrochloride's authenticity with the IR and Chlorides test among others, and acknowledges the product’s conscientious solubility in water and minimal solubility in anhydrous ethanol. We maintain stringent control on residual solvents, ensuring ethanol levels remain below 5000 ppm and methanol below 3000 ppm. Administered orally, this pharmaceutical agent's dosage is contingent upon individual patient needs and medical recommendations, subject to professional healthcare guidance. Despite its profound benefits, it should be noted that Benserazide Hydrochloride is contraindicated for patients with severe hepatic or renal impairments and requires cautious use in patients with a history of cardiovascular diseases, orthostatic hypotension, or psychiatric conditions. Interaction with opioids and antidepressants necessitates careful management. Upholding the highest standards, our product is compliant with Good Manufacturing Practice (GMP) and holds the Certificate of Suitability (CEP)—a rigorous certification ensuring consistency in high-quality production for our corporate customers. With REFARMED CHEMICALS, you are guaranteed a product that not only addresses the therapeutic needs but also embodies the precision and reliability sought after in the pharmaceutical industry.

Products still subject to third-party patent protection might be available solely for R&D purposes.

트리메부틴 말레산염 은 항무스카린성 및 약한 뮤 오피오이드 작용제 효과가 있는 약물입니다. 과민성 대장 증후군 및 기타 위장 장애의 치료에 사용됩니다. 

Ketotifen Hydrogen Fumarate is a specialized pharmaceutical compound with profound implications in the management of allergic conditions. As a white to off-white crystalline powder, it embodies the archetypal pharmaceutical intermediate that serves a critical role in the synthesis of medications aimed at mitigating allergic symptoms. This compound, with the molecular formula C19H19NOS·C4H4O4 and a molecular weight of 425.50 g/mol, is an epitome of pharmacological innovation, designed to alleviate discomfort associated with allergic rhinitis and conjunctivitis, while also playing a preventive role in asthma management. Fabricated with meticulous precision, Ketotifen Hydrogen Fumarate is both soluble in water and ethanol, ensuring versatility in its application for medical formulations. With a melting point between 160-163°C, where it starts decomposing, this substance remains stable under a wide range of conditions, ensuring a dependable shelf-life for pharmaceutical products. When handling this product, adherence to stringent safety guidelines, including the use of personal protective equipment, is imperative to minimize potential contact risks. It demands storage in cool, dry environments, shielded from light and moisture, to preserve its integrity. Respected for its non-sedating nature, Ketotifen distinctively works by inhibiting the discharge of histamine and other mediators from mast cells, thus curtailing the cascade of allergic reactions without inducing significant drowsiness. The side effects are minimal, with mild drowsiness, dry mouth, and nausea being among the most common, while more severe reactions such as confusion or hallucinations are decidedly rare. An advocate for quality and safety, Refarmed Chemicals, a leading pharmaceutical ingredient manufacturer, assures regulatory compliance, with Ketotifen Hydrogen Fumarate approved by the FDA for prescribed use. As such, corporate customers seeking a reliable cornerstone for their allergy-treating formulations will find this product to be a formidable addition to their pharmaceutical repertoire.

Products still subject to third-party patent protection might be available solely for R&D purposes.